Baroreflex Activation Therapy for Left Ventricular Function

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Patients with systolic heart failure experience reduced left ventricular function due to impaired cardiac excitation-contraction coupling and decreased nitric oxide synthase levels, leading to complications such as pulmonary edema and peripheral edema, for which current drug therapies have limitations and side effects.

Innovation Solution

The use of baroreflex activation therapy, involving a system with electrodes and a control system that stimulates baroreceptors to improve left ventricular function through electrical, mechanical, thermal, or chemical means, potentially normalizing gene expression of nitric oxide synthases and β-adrenergic receptor signaling.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If drug therapies are used to directly stimulate cardiac tissue and increase contractility, then cardiac output is improved, but side effects and treatment limitations occur

Engineering Contradiction:
Improvecardiac outputVSAvoidside effects
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent uses baroreceptors as an intermediary element in the cardiovascular reflex arc. By stimulating baroreceptors, the therapy activates endogenous neural pathways (via the nucleus tractus solitarius and vagus nerve) that indirectly improve cardiac function, rather than directly administering drugs to cardiac tissue. This intermediary approach bypasses the harmful side effects of direct cardiac stimulation while achieving therapeutic goals through physiological reflex mechanisms.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If conventional therapies are used to treat systolic heart failure, then some symptomatic relief is achieved, but the underlying left ventricular dysfunction is not adequately addressed

Engineering Contradiction:
Improvetreatment efficacyVSAvoidtreatment versatility
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent changes the therapeutic parameter from direct cardiac stimulation to baroreceptor activation. By stimulating baroreceptors with electrical, mechanical, thermal, or chemical means, the therapy modifies neural signaling parameters that subsequently regulate cardiac function. This parameter change enables treatment of systolic heart failure through a different physiological pathway, improving reliability by addressing the underlying dysfunction rather than just symptoms.

Inventive Principle:
Principle #35Parameter changes

3Adaptability or versatility

If multiple stimulation modes are available for baroreflex activation, then treatment versatility is improved, but device complexity increases

Engineering Contradiction:
Improvestimulation mode versatilityVSAvoiddevice complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent implements a multi-functional baroreflex activation device that can deliver electrical, mechanical, thermal, or chemical stimulation through a single integrated system. The device includes multiple electrodes and control systems that can switch between different stimulation modes, allowing one device to perform multiple therapeutic functions. This universality achieves treatment versatility while managing device complexity through shared hardware components and control architecture.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach improves left ventricular function and structure by enhancing cardiac output and reducing pressures, confirmed through hemodynamic and angiographic measurements, and may be combined with pharmacological agents for enhanced efficacy.

Implementation Method 1

The stimulation provided by the baroreflex activation device may be any suitable stimulation. For example, it can be electrical stimulation, mechanical stimulation, thermal stimulation, chemical stimulation, or combinations thereof.

Methodology Applied
Scientific EffectElectrical stimulation: Electric Field

Data Source

PatentUS8249705B1Devices, systems, and methods for improving left ventricular structure and function using baroreflex activation therapy
Publication Date: 2012.08.21 CVRX INC
  • US8249705B1 patent drawing
  • US8249705B1 patent drawing
  • US8249705B1 patent drawing

AI summary

Described here are devices, systems, and methods for improving left ventricular function in a patient with systolic heart failure with left ventricular dysfunction using baroreflex activation therapy. In general the systems have at least one electrode and a control system in communication with the electrode, the control system including a processor and memory, wherein the memory includes software defining a stimulus regime configured to effect improvement in left ventricular function. The methods for improving left ventricular function in a subject typically include identifying a patient in need of left ventricular function improvement and stimulating a baroreceptor with a baroreceptor activation device to improve left ventricular function.